Abstract

Purpose: We aimed to investigate the relationship between clinical characteristics, radiographic features, and the viral load of patients with coronavirus disease 2019 (COVID-19).Methods and Materials: We retrospectively collected 56 COVID-19 cases from two institutions in Hunan province, China. The basal clinical characteristics, detail imaging features and follow-up CT changes were evaluated and the relationship with the viral load was analyzed.Results: GGO (48, 85.7%) and vascular enlargement (44, 78.6%) were the most frequent signs in COVID-19 patients. Of the lesions, 64.3% of the margins were uneasily differentiated. However, no significant correlations were found in terms of leucocytes, neutrophils, lymphocytes, platelets, and C-reactive protein (all P > 0.05). In contrast, the uneasily differentiated margin was negatively correlated with the Ct value (r = −0.283, P = 0.042), that is, an uneasily differentiated margin indicated a lower Ct value (P = 0.043). Patients with a lower Ct value were likely to present a progress follow-up change (P = 0.022). The Ct value at baseline could predict a progress follow-up change with an AUC of 0.685 (Cut-off value = 29.48). All four patients with normal CT findings presented new lesion(s) on follow-up CT scans.Conclusion: The viral load of COVID-19 is negatively correlated with an uneasily differentiated lesion margin on initial CT scan images and the Ct value should noted when making a diagnosis. In addition, following-up CT scans are necessary for patients who presented a normal CT at the initial diagnosis, especially for those with a low Ct value.

Highlights

  • A cluster of “unknown viral pneumonia” cases in Wuhan, China, was reported to World Health Organization (WHO) on December 31 2019 [1]

  • Data were presented as numbers, except for computed tomography (CT) score, which presented as median (Inter quartile range)

  • It is noted that 4 (7.1%) patients denied any direct exposure history and indirect exposure to confirmed patients and 17 (30.3%) patients were related to a family outbreak

Read more

Summary

Introduction

A cluster of “unknown viral pneumonia” cases in Wuhan, China, was reported to World Health Organization (WHO) on December 31 2019 [1]. A novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified through deep sequencing analysis [2]. The genome sequence findings suggested that the presence of COVID-19 was closely related to another coronavirus termed severe acute respiratory syndrome (SARS)-related CoV [5]. Assessing the disease severity of COVID-19 is still vital for clinical treatment scenarios and taking action in advance to avoid the presence of rapid progress. The assessment of the Ct value of the virus needs a real-time reverse transcriptionpolymerase chain reaction test (RT-PCR), which has inherent disadvantages including possible false positive results and a long turnaround time. Identifying the potential clinical alternative factors of the Ct value may help us assess the disease severity efficiently

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call